Markets:

Overview

News

Currencies

International

Treasuries

Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

0.9800 -0.0700 (-6.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Skye Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 26, 2025

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.

Via Benzinga

Could This New Drug Be The Safer Way To Fight Obesity? ↗

September 19, 2025

Skye Bioscience reported favorable Phase 1b nimacimab results, with analysts citing strong potential in obesity alongside GLP-1 therapies.

Via Benzinga

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data ↗

September 05, 2025

Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Skye (SKYE) Q2 R&D Soars 249% No Revenue ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

In today's session, these stocks are experiencing unusual volume. ↗

June 24, 2025

Which stocks have an unusual volume on Tuesday?

Via Chartmill

What's going on in today's session ↗

June 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 23, 2025

Via Benzinga

Which stocks are experiencing notable movement on Monday? ↗

June 23, 2025

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

These stocks are moving in today's pre-market session ↗

June 23, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News ↗

April 15, 2025

Via Stocktwits

Topics Animal Testing Artificial Intelligence Stocks

Top stock movements in today's session. ↗

April 15, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models ↗

April 15, 2025

Skye shares surge after new data shows nimacimab reduces weight over 30% with tirzepatide, with stable potency and promising obesity treatment potential.

Via Benzinga

Tuesday's session: top gainers and losers ↗

April 15, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 15, 2025

Via Benzinga

The market is filled with gapping stocks in Tuesday's session. ↗

April 15, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

Crude Oil Moves Lower; Citigroup Posts Upbeat Results ↗

April 15, 2025

Via Benzinga

Nasdaq Surges 100 Points; Bank of America Earnings Top Views ↗

April 15, 2025

Via Benzinga

Earnings Scheduled For March 20, 2025 ↗

March 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 12, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

February 11, 2025

Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Top Picks For 2025: Skye Bioscience ↗

February 02, 2025

Skye Bioscience is developing a peripheral restricted CB1 antibody to treat obesity by restoring leptin sensitivity and increasing fat metabolism, while avoiding the CB1-induced THC/neuro side effects....

Via Talk Markets

Topics Stocks / Equities

MarketBeat Week in Review – 10/7 - 10/11

October 12, 2024

Stocks delivered another winning week, but the latest inflation readings dampened hopes for aggressive rate cuts and turned attention toward earnings

Via MarketBeat

Topics Artificial Intelligence Economy

Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar

October 09, 2024

Skye Bioscience has incredible potential upside, according to Wall Street analysts. It is striving to make a new weight loss drug, that could work with GLP-1s.

Via MarketBeat

3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore

October 04, 2024

Check out these three micro-cap companies that have a big opportunity to succeed, but also significant a risk of failure.

Via MarketBeat

Topics Bankruptcy

Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players ↗

September 20, 2024

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus...

Via Benzinga

US Stocks Edge Lower; FedEx Earnings Miss Views ↗

September 20, 2024

Via Benzinga

Topics Earnings

Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 16, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.